Equity Brief · Consumer Cyclical2026-05-20
7211.T·Consumer Cyclical

Mitsubishi Motor Corp

I · AI Analysis

The brief

Mitsubishi Motors develops, manufactures, and sells passenger vehicles including electric vehicles (EVs), plug-in hybrids (PHEVs), SUVs, pickup trucks, MPVs, minicars, and traditional cars under the Mitsubishi brand [Company Overview]. The company operates in Japan, Europe, North America, Oceania, and across Asia, and also has a financial services business [Company Overview].

Mitsubishi Motors is a Japanese automaker producing EVs, PHEVs, SUVs, pickup trucks, and passenger vehicles sold globally [Company Overview]. The company reported full-year 2026 sales of ¥2.9 trillion but net income of only ¥10 billion, reflecting pressure from US import tariffs [Simply Wall St]. The stock has fallen 28% over 90 days and 19% over one year, though it rebounded 7-8% in the week following the latest earnings [Simply Wall St].

Mitsubishi Motors shows weak profitability and negative free cash flow despite revenue growth, raising sustainability concerns.

The brief AI analysisConfidence 6/10

Sentinellis health

5.8/10

Moderate concerns

Market capitalisation

JPY 462.1B

Revenue (TTM)

JPY 2.9T

Explainers

How we read these numbers

Plain-English guides · no account needed

II · Recent news

What moved

1 story · ranked by relevance

  • Macro2026-05-12

    A Look At Mitsubishi Motors (TSE:7211) Valuation After Earnings Hit From US Tariffs And Forecast Recovery

    Simply Wall St

Premium · Free with any account

US import tariffs have materially pressured profitability, contributing to the razor-thin 0.3% net margin [Simply Wall St] [Yahoo Finance].

1 of 5 risks in this report

Risks

5

Opportunities

5

Red flags

3

Leadership

10

12 more findings in the full report — free with any account.

Unlock the full Mitsubishi Motor Corp analysis

Create a free account to access the complete AI-generated report with inline citations.

  • 5 risks, 5 opportunities and 3 red flags — each with its source
  • 100+ financial metrics with charts and benchmarks
  • Full news summaries with source links
  • Executive team and compensation details
  • PDF export for offline use
Unlock all 13 findings3 free reports · No credit card

III · Related

You might also read

Same sector · Consumer Cyclical — or comparable health

Want this for your watchlist?

Read three companies free. No card.

Get 3 free reports

Produced 20 May 2026, 19:57 UTC

Figures come from company filings and market data. The Sentinellis health score and the wording attached to it are our interpretation of those figures, not numbers the company reported.

Not investment advice and not a recommendation to buy or sell. Sentinellis holds no positions in the companies it covers, takes no payment from issuers, and has no broker referral arrangements.

How every figure and score is calculated